Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

This study has been completed.

Study NCT00162630. Last updated on September 13, 2006. Information provided by Hvidovre University Hospital

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Official Title ^†

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Brief Summary

To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Detailed Description

Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Study Phase

Phase IV

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study

Primary Outcome Measure ^†

Pain relief within 3 hours

Secondary Outcome Measure ^†

Nausea
Pain on transfer
Discomfort with block placement

Condition ^†

Hip Fracture

Intervention ^†

Procedure: Fascia Iliaca Compartment Blockade

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

May 2003

Completion Date

March 2006

Eligibility Criteria ^†

Inclusion Criteria:

Primary hip fracture suspected
able to give informed consent
no substance abuse
no regular opioid therapy
no opioid treatment within the last 6 hours
morphine intolerance
allergies to local anaesthetics

Exclusion Criteria:

Fracture ruled out on x-ray

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Denmark

Administrative Information Fields

NCT ID ^†

NCT00162630

Organization ID

HHSG-rct-04

Secondary IDs ^††

Study Sponsor ^†

Hvidovre University Hospital

Collaborators ^††

IMK-fonden

Investigators ^†

Study Director:

Nicolai B Foss, MD

Hvidovre University Hospital

Information Provided By

Hvidovre University Hospital

Verification Date

September 2006

First Received Date ^†

September 8, 2005

Last Updated Date

September 13, 2006

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.